Global Markets for Antifungal Agents (Anti - Infective) - Industry Analysis, Share, Size, Trends, Opportunities and Forecast, 2012 – 2020 The global antifungal agents market is already established. However, it is necessary to understand and examine the antifungal market growth of developing products in terms of effectiveness. Fungi have proved drug-resistant to some compounds and therapies in the recent past. Fungal infections in humans occur due to unhygienic, moist and unclean environment. Even, dermal infections are mostly tinea infections, which affect hair, scalp, nails, and the skin. Besides this, cases of candidiasis, mucormycosis, and meningitis are found in people, which may not be lethal but cause discomfort and uneasiness for the patients and the surroundings. Thus, where cases of fungal infestations are on a steep rise in humans, plants, animals, and the environment with some having lethal consequences, identifying new antifungal research, development and new drug applications is critical to grow in the marketplace. Global anti-infective drugs market is expected to reach about 102 billion billion by the end of 2015. The antifungal agents market provides immense opportunities as number of antifungal drug launches in recent years have been very less in comparison to other anti-infective drugs. Antifungal therapies intend at eradicating fungi through several action mechanisms, including destruction of cell walls, inhibition of cell division, or modification of fungal DNA and cell functioning. The antifungal therapy agents market comprises several applications – powders, drugs, ointments, and pastes. Increasing unhygienic conditions in developing countries and in some developed countries worldwide, and rising cases of resistant fungal infections are major growth factors for the global antifungal agents market. However, preferred use of traditional medicines to control fungus by infected individuals and allergic reaction to certain antifungal drugs may impede the growth of this market. Although these restraints are prevalent in the market, the antifungal drugs market’s shift to over-the-counter status has already initiated the growth for this market. Even, recent technological advancements are easing things up for physicians in extracting and treating the infection effectively. The global market for antifungal agents is segmented in terms of types, applications and geography. The global antifungal agents market by type is classified into echinocandins, azoles, ployenes, and other. On the basis of applications, this market is segmented into powders, ointments, drugs and pastes. Markets by therapeutic indications are segmented as aspergillosis, dermatophytosis, candidiasis and others. The global antifungal agents market segmentation by geography includes North America, Asia Pacific, Europe, Latin America and RoW. Leading market players are Pfizer, Glaxosmithkline, Bayer Healthcare, Kramer Laboratories, Novartis, Enzon
Pharmaceuticals, Abbott Laboratories, Sanofi-Aventis, Merck & Co., and Gilead. Research development collaborations, mergers and acquisitions, and product launches are certain market strategies that these companies have been adopting. For example, Pfizer received approval by the European Commission to market Vfend for the treatment of life-threatening fungal infections. To Get More Information Visit At: http://www.bigmarketresearch.com/antifungalagents-market Market attractiveness analysis, compares various drug type, therapeutic indication and applications within their respective markets along with factors responsible for the most attractive market. Market attractiveness analysis for the most attractive geographical region worldwide is also considered and has detailed study of factors responsible for rapid growth in the regions. Various economic factors which are significant in determining market trend, buying decisions and market attractiveness had been analyzed for market estimation and forecasting. Detailed elaboration of drivers, restraints and opportunities in the report will enable in strategic decision making with perceptive to identify potential market. In addition to this, the study also discusses various environmental and regulatory factors critical for the market growth. Thus, estimation of market numbers, with due consideration to all these factors has helped in enhancing the scope of the report. This analysis will support stakeholders such as manufacturers and distributers in identifying and capturing markets with high potential. Historical data is provided for 2011, 2012 whereas forecast is available through 2020 in terms of revenue (million) for each and every segments. The Global Antifungal Agents Market Segmentation is as follows: By Drug Type Echinocandins • Azoles • Ployenes • Allylamines • Others By Therapeutic Indication •
• • • •
Aspergillosis, Dermatophytosis Candidiasis Others
By Application
Powders • Ointments • Drugs • Pastes By Geography •
• • • •
North America Asia Pacific Europe Middle East and Africa (EMEA) Latin America
About Us: With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us: Sona Padman 5320 SW Macadam Avenue, Suite 100, Portland, OR 97239, United States. Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Email: sales@bigmarketresearch.com Web: http://www.bigmarketresearch.com